An Innovative Platform in Oral, Nasal and Inhalation for Monoclonal Antibody Administration Proprietary inhalation delivery of anti-IL-6R mAb for COVID-19 treatment Advanced clinical programs in Crohn's Disease, progressive Multiple Sclerosis, and Hepatocellular Carcinoma August 2020 Corporate Presentation https://www.tizianalifesciences.com/ NASDAQ: TLSA AIM: TILS DISCLAIMER AND FORWARD LOOKING STATEMENTS 2 The content of this presentation has been prepared for the purpose of providing general information ...